NanoSALV - Wound Care | Healing | Inflammation | Antimicrobial

Solid State Heterogeneous Biocatalysts

Everyone will experience a wound or skin challenge in their lifetime.

We all deserve the peace of mind knowing we will heal.

NanoSALV Catalytic Advanced Wound Care Treatment Matrix

A Canadian made, award winning, Health Canada approved medical device. This technology has been used to increase the speed of healing wounds, from small skin tears to chronic wounds, to a wide range of dermatological challenges.

Purchase Now

Improved wound healing by

~57.6%¹

Reduced wound care costs by

~46%²

Improved mental health and quality of life for patients and healthcare staff

Achieving Patient, Economic, & Operational Benefits through Patented Catalytic Technology

Catalysts make reactions happen better and faster. NanoSALV’s unique catalytic technology optimizes natural wound healing, resulting in better and faster healing outcomes.

The process of wound healing is a carefully coordinated set of events that require a significant amount of energy and resources. This careful coordination is often disrupted by factors such as aging, diabetes, poor nutrition, and many others.

Catalysts help return these events into an optimized, coordinated sequence that ultimately improves wound healing.

In addition to promoting healing, NanoSALV reduces and modulates inflammation, as well as provides safe broad-spectrum infection control within the protective matrix barrier.

Indications

NanoSALV’s simple design makes it easy to apply to a variety of wound types, shapes, and sizes, including early-stage intervention, surgical wounds, chronic-stage wounds, and a variety of skin health concerns.

For Clinicians

For Patients

Health Canada has approved this product as a medical device with the following claims:

Actively Supports and Promotes Wound Healing
Reduces Inflammation
Broad-Spectrum Antimicrobial Effect within the Protective Matrix Barrier

NanoTess in the News

CAN Health Network partners with Alberta Health Services and NanoTess to implement and evaluate NanoSALV Catalytic across multiple healthcare settings

U of C's W21C leads pivotal study validating the effectivity, safety and ease of integration of the NanoSALV Catalytic Technology

Calgary Herald highlights the social enterprise mission of NanoTess against the silent pandemic of complex wounds

Ontario-based GPO Mohawk Medbuy awards NanoTess an Innovation Contract, providing access of NanoSALV Catalytic to Canadian hospitals and health providers

Discover how NanoSALV Catalytic can decrease wound/skin care costs, increase nursing capacity and improve the physical and emotional wellbeing of your patients

Certified Aboriginal Business MSS Ltd. forges partnership with NanoTess in delivering advanced wound care to Indigenous communities, leaving no one behind

Contact Our Partner Success Team

Studies, resources, and clinical peer references are available to assist in the integration of NanoSALV Catalytic within your health care organization. Contact our partner success team for more information.

Canadian Made, Globally Compassionate

Your purchase supports limb saving research to improve patient outcomes through nanotechnology innovations.